Bull Flag Stocks
REC.MI is forming a bull flag pattern, suggesting a potential continuation of its upward trend.
RECORDATI INDUSTRIA CHIMICA (REC.MI) Stock Price & Overview
BIT:REC • IT0003828271
Current stock price
48.84 EUR
+0.14 (+0.29%)
Last:
The current stock price of REC.MI is 48.84 EUR. Today REC.MI is up by 0.29%. In the past month the price increased by 5.67%. In the past year, price increased by 4.72%.
REC.MI Key Statistics
52-Week Range43.76 - 55.35
Current REC.MI stock price positioned within its 52-week range.
1-Month Range43.76 - 50.65
Current REC.MI stock price positioned within its 1-month range.
- Market Cap
- 10.214B
- P/E
- 22.61
- Fwd P/E
- 16.43
- EPS (TTM)
- 2.16
- Dividend Yield
- 2.75%
REC.MI Stock Performance
Today
+0.29%
1 Week
-1.21%
1 Month
+5.67%
3 Months
-1.49%
Longer-term
6 Months -5.17%
1 Year +4.72%
2 Years -2.42%
3 Years +17.04%
5 Years +6.54%
10 Years N/A
REC.MI Stock Chart
REC.MI Stock Screens
REC.MI currently appears in the following ChartMill screener lists.
REC.MI Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to REC.MI. When comparing the yearly performance of all stocks, REC.MI is a bad performer in the overall market: 63.1% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
REC.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to REC.MI. REC.MI has an average financial health and profitability rating.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
REC.MI Earnings
Next Earnings DateMay 12, 2026
Last Earnings DateFeb 17, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
REC.MI Forecast & Estimates
16 analysts have analysed REC.MI and the average price target is 59.3 EUR. This implies a price increase of 21.42% is expected in the next year compared to the current price of 48.84.
For the next year, analysts expect an EPS growth of 15.43% and a revenue growth 6.28% for REC.MI
Analysts
Analysts78.75
Price Target59.3 (21.42%)
EPS Next Y15.43%
Revenue Next Year6.28%
REC.MI Groups
Sector & Classification
REC.MI Financial Highlights
Over the last trailing twelve months REC.MI reported a non-GAAP Earnings per Share(EPS) of 2.16. The EPS increased by 12.22% compared to the year before.
Income Statements
Revenue(TTM)2.62B
Net Income(TTM)443.62M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.94% | ||
| ROA | 8.45% | ||
| ROE | 23.11% | ||
| Debt/Equity | 1.12 |
Chartmill High Growth Momentum
EPS Q2Q%51.66%
Sales Q2Q%10.64%
EPS 1Y (TTM)12.22%
Revenue 1Y (TTM)11.82%
REC.MI Ownership
Ownership
Inst Owners30.78%
Shares209.13M
Float106.69M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
REC.MI Competitors/Peers
The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 9.4 | 97.617B | ||
| SAN | SANOFI | 9.36 | 97.205B | ||
| SNW | SANOFI | 9.36 | 97.193B | ||
| UCB | UCB SA | 26.04 | 53.49B | ||
| UNC | UCB SA | 25.91 | 53.218B | ||
| MRK | MERCK KGAA | 14.18 | 48.63B | ||
| 1MRK | MERCK KGAA | 13.62 | 46.695B | ||
| 1BAYN | BAYER AG-REG | 9.21 | 39.808B | ||
| BAYN | BAYER AG-REG | 9.12 | 39.415B | ||
| IPN | IPSEN | 13.49 | 14.315B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 10.059B | ||
| VIRP | VIRBAC SA | 16.83 | 3.02B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About REC.MI
Company Profile
Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. The company is headquartered in Milan, Milano. The company promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The firm is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. The company operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The firm owns and operates through Natural Point srl also in the food supplement sector.
Company Info
IPO: 1984-01-01
RECORDATI INDUSTRIA CHIMICA
Via Matteo Civitali, 1
Milan MILANO IT
Employees: 4654
Phone: 3902487871
RECORDATI INDUSTRIA CHIMICA / REC.MI FAQ
What does RECORDATI INDUSTRIA CHIMICA do?
Recordati SpA engages in the research, development, manufacture, and marketing of pharmaceuticals. The company is headquartered in Milan, Milano. The company promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The firm is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. The company operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The firm owns and operates through Natural Point srl also in the food supplement sector.
What is the stock price of RECORDATI INDUSTRIA CHIMICA today?
The current stock price of REC.MI is 48.84 EUR. The price increased by 0.29% in the last trading session.
What is the dividend status of RECORDATI INDUSTRIA CHIMICA?
RECORDATI INDUSTRIA CHIMICA (REC.MI) has a dividend yield of 2.75%. The yearly dividend amount is currently 1.3.
What is the ChartMill rating of RECORDATI INDUSTRIA CHIMICA stock?
REC.MI has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the PE ratio for REC stock?
The PE ratio for RECORDATI INDUSTRIA CHIMICA (REC.MI) is 22.61. This is based on the reported non-GAAP earnings per share of 2.16 and the current share price of 48.84 EUR.
What is the next earnings date for REC stock?
RECORDATI INDUSTRIA CHIMICA (REC.MI) will report earnings on 2026-05-12.